stockrowNuvation Bio Inc. (NUVB) vs Precigen, Inc. (PGEN)
- Nuvation Bio Inc. NUVB 4.17 −0.48%
- Precigen, Inc. PGEN 4.43 +4.98%
Nuvation Bio Inc. and Precigen, Inc. are both Biotechnology companies. Nuvation Bio Inc. and Precigen, Inc. are of similar size ($1.5B and $1.5B). Nuvation Bio Inc. has negative trailing earnings, so its P/E is not meaningful; Precigen, Inc. trades at 60.3×. Precigen, Inc. grew revenue faster over the last twelve months: 2,387.6% against 654.2%. Precigen, Inc. has the higher net margin (15.6% vs −67.4%) and the higher return on invested capital (15.9% vs 0.00%). Across the 17 metrics below, Precigen, Inc. leads on 12 and Nuvation Bio Inc. on 5.
Valuation
Profitability
| Metric | NUVB | PGEN | Biotechnology median |
|---|---|---|---|
| Gross margin | 85.79% | 91.42% | 68.51% |
| Operating margin | (61.17%) | 21.43% | 0.00% |
| Net margin | (67.38%) | 15.55% | 0.00% |
| Free cash flow margin | (53.62%) | (47.35%) | 0.00% |
| Return on equity | (49.09%) | 38.84% | (51.96%) |
| Return on assets | (19.70%) | 12.73% | (46.06%) |
| Return on invested capital | 0.00% | 15.93% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack